JP2000511529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000511529A5 JP2000511529A5 JP1997542424A JP54242497A JP2000511529A5 JP 2000511529 A5 JP2000511529 A5 JP 2000511529A5 JP 1997542424 A JP1997542424 A JP 1997542424A JP 54242497 A JP54242497 A JP 54242497A JP 2000511529 A5 JP2000511529 A5 JP 2000511529A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1879496P | 1996-05-31 | 1996-05-31 | |
| US60/018,794 | 1996-05-31 | ||
| PCT/US1997/007650 WO1997045403A1 (en) | 1996-05-31 | 1997-05-12 | Aryl substituted cyclic amines as selective dopamine d3 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000511529A JP2000511529A (ja) | 2000-09-05 |
| JP2000511529A5 true JP2000511529A5 (enExample) | 2005-01-13 |
Family
ID=21789817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09542424A Ceased JP2000511529A (ja) | 1996-05-31 | 1997-05-12 | 選択的ドーパミンｄ３リガンドとしてのアリール置換環式アミン |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6084130A (enExample) |
| EP (1) | EP0923542B1 (enExample) |
| JP (1) | JP2000511529A (enExample) |
| KR (1) | KR20000016147A (enExample) |
| CN (1) | CN1159292C (enExample) |
| AT (1) | ATE247639T1 (enExample) |
| AU (1) | AU720414B2 (enExample) |
| CA (1) | CA2255612A1 (enExample) |
| CZ (1) | CZ370198A3 (enExample) |
| DE (1) | DE69724259T2 (enExample) |
| DK (1) | DK0923542T3 (enExample) |
| ES (1) | ES2205227T3 (enExample) |
| FI (1) | FI982572A7 (enExample) |
| NO (1) | NO314398B1 (enExample) |
| NZ (1) | NZ332538A (enExample) |
| PL (1) | PL187296B1 (enExample) |
| PT (1) | PT923542E (enExample) |
| RU (1) | RU2185372C2 (enExample) |
| SI (1) | SI0923542T1 (enExample) |
| SK (1) | SK282725B6 (enExample) |
| WO (1) | WO1997045403A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI274750B (en) * | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| EP1088821A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
| AU2001234453A1 (en) | 2000-02-22 | 2001-09-03 | Pharmacia And Upjohn Company | (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands |
| US6462234B2 (en) | 2000-09-18 | 2002-10-08 | Pharmacia & Upjohn Company | Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide |
| EP1193268A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
| WO2003068732A2 (en) * | 2002-02-13 | 2003-08-21 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| CA2566526C (en) * | 2004-06-02 | 2012-10-23 | F. Hoffmann-La Roche Ag | Naphthaline derivatives useful as histamine-3-receptor ligands |
| EP2371814A1 (en) * | 2004-10-14 | 2011-10-05 | Abbott GmbH & Co. KG | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| JP4754570B2 (ja) * | 2004-10-14 | 2011-08-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ドーパミンｄ３受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物 |
| EP1807392A1 (en) | 2004-10-14 | 2007-07-18 | Abbott GmbH & Co. KG | 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| US7851463B2 (en) | 2004-10-14 | 2010-12-14 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| EP2439203B1 (en) * | 2004-10-14 | 2014-11-19 | AbbVie Deutschland GmbH & Co KG | Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| WO2006040180A1 (en) * | 2004-10-14 | 2006-04-20 | Abbott Gmbh & Co. Kg | Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| TW200800959A (en) * | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
| MX2007015772A (es) * | 2005-06-17 | 2008-02-22 | Wyeth Corp | Compuestos utiles como inhibidores de serotonina y agonistas y antagonistas de 5-ht-1a. |
| TW200831096A (en) * | 2006-11-28 | 2008-08-01 | Wyeth Corp | Metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
| GB0721332D0 (en) * | 2007-10-31 | 2007-12-12 | Motac Neuroscience Ltd | Medicaments |
| GB0721333D0 (en) * | 2007-10-31 | 2007-12-12 | Motac Neuroscience Ltd | Medicaments |
| CN102786483B (zh) * | 2011-05-19 | 2016-03-30 | 复旦大学 | 4-（4-苯基哌嗪基）喹唑啉类衍生物的药用用途 |
| TW201617309A (zh) * | 2014-07-30 | 2016-05-16 | 赫孚孟拉羅股份公司 | ６－胺基－５，６，７，８－四氫萘－２－基或３－胺基唍－７－基衍生物 |
| US11130740B2 (en) | 2017-04-25 | 2021-09-28 | Arbutus Biopharma Corporation | Substituted 2,3-dihydro-1H-indene analogs and methods using same |
| CN110041318B (zh) * | 2018-01-17 | 2022-07-29 | 中国科学院上海药物研究所 | 一类多巴胺d5受体激动剂及其制备和应用 |
| US12083118B2 (en) | 2018-03-29 | 2024-09-10 | Arbutus Biopharma Corporation | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752659A1 (de) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
| FR2512814A1 (fr) * | 1981-09-16 | 1983-03-18 | Synthelabo | Derives d'amino-2 tetrahydro-1,2,3,4 naphtalene, leur preparation et leur application en therapeutique |
| US4448990A (en) * | 1982-11-16 | 1984-05-15 | Eli Lilly And Company | Hydroxyaminotetralincarboxamides |
| JPS6169747A (ja) * | 1984-08-31 | 1986-04-10 | Otsuka Pharmaceut Co Ltd | ２，３―ジヒドロ―１ｈ―インデン誘導体及びその製造法 |
| DE3572485D1 (en) * | 1984-12-22 | 1989-09-28 | Thomae Gmbh Dr K | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| US5225596A (en) * | 1989-01-09 | 1993-07-06 | The Upjohn Company | Halo substituted aminotetralins |
| ES2149869T3 (es) * | 1993-03-25 | 2000-11-16 | Upjohn Co | Derivados de indol sustituidos por formil o ciano con actividad dopominergica. |
| ES2139750T3 (es) * | 1993-08-06 | 2000-02-16 | Upjohn Co | 2-aminoindanos como ligandos selectivos d3 de la dopamina. |
| WO1996023760A1 (en) * | 1995-02-01 | 1996-08-08 | Pharmacia & Upjohn Company | 2-aminoindans as selective dopamine d3 ligands |
| DE69608551T2 (de) * | 1995-03-27 | 2001-01-18 | Smithkline Beecham P.L.C., Brentford | Bicyclische amin-derivate und ihre verwendung als antipsychotische wirkstoffe |
-
1997
- 1997-05-12 CN CNB971943265A patent/CN1159292C/zh not_active Expired - Fee Related
- 1997-05-12 JP JP09542424A patent/JP2000511529A/ja not_active Ceased
- 1997-05-12 SK SK1488-98A patent/SK282725B6/sk unknown
- 1997-05-12 ES ES97925470T patent/ES2205227T3/es not_active Expired - Lifetime
- 1997-05-12 DK DK97925470T patent/DK0923542T3/da active
- 1997-05-12 CA CA002255612A patent/CA2255612A1/en not_active Abandoned
- 1997-05-12 KR KR1019980709715A patent/KR20000016147A/ko not_active Ceased
- 1997-05-12 CZ CZ983701A patent/CZ370198A3/cs unknown
- 1997-05-12 DE DE69724259T patent/DE69724259T2/de not_active Expired - Fee Related
- 1997-05-12 WO PCT/US1997/007650 patent/WO1997045403A1/en not_active Ceased
- 1997-05-12 AT AT97925470T patent/ATE247639T1/de not_active IP Right Cessation
- 1997-05-12 SI SI9730586T patent/SI0923542T1/xx unknown
- 1997-05-12 PT PT97925470T patent/PT923542E/pt unknown
- 1997-05-12 AU AU30601/97A patent/AU720414B2/en not_active Ceased
- 1997-05-12 RU RU98123954/04A patent/RU2185372C2/ru not_active IP Right Cessation
- 1997-05-12 EP EP97925470A patent/EP0923542B1/en not_active Expired - Lifetime
- 1997-05-20 US US08/859,587 patent/US6084130A/en not_active Expired - Fee Related
-
1998
- 1998-11-02 NZ NZ332538A patent/NZ332538A/en unknown
- 1998-11-02 PL PL97330207A patent/PL187296B1/pl not_active IP Right Cessation
- 1998-11-27 FI FI982572A patent/FI982572A7/fi not_active IP Right Cessation
- 1998-11-30 NO NO19985599A patent/NO314398B1/no not_active Application Discontinuation